1. Home
  2. GIB vs ICLR Comparison

GIB vs ICLR Comparison

Compare GIB & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CGI Inc.

GIB

CGI Inc.

N/A

Current Price

$81.97

Market Cap

14.4B

ML Signal

N/A

Logo ICON plc

ICLR

ICON plc

N/A

Current Price

$195.61

Market Cap

13.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GIB
ICLR
Founded
1976
1990
Country
Canada
Ireland
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.4B
13.1B
IPO Year
1999
2001

Fundamental Metrics

Financial Performance
Metric
GIB
ICLR
Price
$81.97
$195.61
Analyst Decision
Buy
Buy
Analyst Count
15
18
Target Price
$86.09
★ $231.29
AVG Volume (30 Days)
412.8K
★ 1.2M
Earning Date
11-11-2026
10-27-2026
Dividend Yield
★ 0.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.80
N/A
Revenue Next Year
$2.74
$4.60
P/E Ratio
$13.59
★ $12.91
Revenue Growth
N/A
N/A
52 Week Low
$59.63
$66.57
52 Week High
$95.20
$219.04

Technical Indicators

Market Signals
Indicator
GIB
ICLR
Relative Strength Index (RSI) 63.05 53.47
Support Level $68.57 $157.92
Resistance Level $82.35 $219.04
Average True Range (ATR) 2.08 8.19
MACD -0.26 -1.38
Stochastic Oscillator 67.66 37.02

Price Performance

Historical Comparison
GIB
ICLR

About GIB CGI Inc.

CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: